ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin‐bound paclitaxel with or without CC‐486 as second‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC)

ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin‐bound paclitaxel with or without CC‐486 as second‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC)

<p><strong>Background</strong> This randomized phase 2 trial compared the efficacy and safety of second‐line nanoparticle albumin‐bound paclitaxel (nab‐paclitaxel) with or without the addition of CC‐486 (an oral formulation of 5‐azacytidine) in patients with advanced‐stage, nonsqua...

Полное описание

Библиографические подробности
Главные авторы:	Morgensztern, D, Cobo, M, Ponce Aix, S, Postmus, PE, Lewanski, CR, Bennouna, J, Fischer, JR, Juan-Vidal, O, Stewart, DJ, Fasola, G, Ardizzoni, A, Bhore, R, Wolfsteiner, M, Talbot, DC, Jin Ong, T, Govindan, R, On Behalf Of The Abound L Investigators
Формат:	Journal article
Язык:	English
Опубликовано:	Wiley 2018

Схожие документы

ABOUND.2L+: nab-paclitaxel (nab-P) +/- CC-486 or durvalumab in previously treated patients with advanced non-small cell lung cancer (NSCLC)
по: Morgensztern, D, и др.
Опубликовано: (2017)

Efficacy and safety of second- or third-line nab-paclitaxel + durvalumab in patients with advanced NSCLC (ABOUND.2L+)
по: Morgensztern, D, и др.
Опубликовано: (2018)

Quality of life in patients with advanced NSCLC treated in second- or third-line with nab-paclitaxel + durvalumab: abound.2l+
по: Talbot, D, и др.
Опубликовано: (2018)

Nab-paclitaxel + durvalumab as second- or third-line treatment of advanced NSCLC: results from ABOUND.2l+
по: Govindan, R, и др.
Опубликовано: (2017)

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)
по: Daniel Morgensztern, и др.
Опубликовано: (2021-02-01)

Quality of life with second or third line nab-paclitaxel-based regimens in advanced non-small-cell lung cancer
по: Ponce Aix, S, и др.
Опубликовано: (2020)

nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC
по: Corey J. Langer, и др.
Опубликовано: (2018-07-01)

nab-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis
по: Corey J. Langer, и др.
Опубликовано: (2021-01-01)

Pharmacokinetics and Pharmacodynamics with Extended Dosing of CC-486 in Patients with Hematologic Malignancies.
по: Eric Laille, и др.
Опубликовано: (2015-01-01)

nab-Paclitaxel–Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2
по: Ajeet Gajra, и др.
Опубликовано: (2018-07-01)

The uses of anxiety: Grace Abounding to the Chief of Sinners (1666)
по: Seymour, L
Опубликовано: (2023)

Short Toxin-like Proteins Abound in Cnidaria Genomes
по: Michal Linial, и др.
Опубликовано: (2012-11-01)

Misperceptions of "light" cigarettes abound: National survey data
по: Thomson George, и др.
Опубликовано: (2009-05-01)

Aboundance, Diversity and Distribution of Ichthyoplanktons in Creeks and Coastal Waters of Khouzestan Province
по: S. Dehghan; A. Savari; P. Kochenin; J. Ghafle marammazi
Опубликовано: (1999-01-01)

The Jurisdictional Basis, Elements and Remedies in the Action for Breach of Confidence - Uncertainty Abounds
по: Leo Tsaknis

Features of fibrosis regression abound in "non-cirrhotic" patients with resected hepatocellular carcinoma.
по: Christine E Orr, и др.
Опубликовано: (2022-01-01)

Improbabilities abound”: Daphne du Maurier’s Rule Britannia and the speculative political future
по: Aoife Byrne
Опубликовано: (2015-07-01)

Features of fibrosis regression abound in “non-cirrhotic” patients with resected hepatocellular carcinoma
по: Christine E. Orr, и др.
Опубликовано: (2022-01-01)

Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC
по: Véronique Hofman, MD, PhD, и др.
Опубликовано: (2023-02-01)

Phase III, randomized, placebo-controlled trial of CC-486 (Oral Azacitidine) in patients with lower-risk myelodysplastic syndromes
по: Garcia-Manero, G, и др.
Опубликовано: (2021)

An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors
по: Neda Stjepanovic, и др.
Опубликовано: (2020-10-01)

Exodus, Psalms and Hebrews: A God abounding in steadfast love (Ex 34:6)
по: Alphonso Groenewald
Опубликовано: (2008-03-01)

Efficacy of paclitaxel‐carboplatin with bevacizumab as a late‐line therapy for patients with advanced nonsquamous non‐small cell lung cancer: A platinum rechallenge
по: Jun Sugisaka, и др.
Опубликовано: (2023-11-01)

Ticks and Tick-Borne Pathogens Abound in the Cattle Population of the Rabat-Sale Kenitra Region, Morocco
по: Latifa Elhachimi, и др.
Опубликовано: (2021-12-01)

Soils rich in biological ice-nucleating particles abound in ice-nucleating macromolecules likely produced by fungi
по: F. Conen, и др.
Опубликовано: (2018-07-01)

Length Frequency, Sex Ratio and Relative Aboundance (CPUE) of Astacus leptoductylus in Arass Reservior (1997-98)
по: M. Karimpor; N. Hosseinpor
Опубликовано: (1999-01-01)

Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non–small cell lung cancer patients with impaired renal function: RESTART trial
по: Yoshimasa Shiraishi, и др.
Опубликовано: (2022-09-01)

Computer processor unit 486
по: Universiti Teknologi Malaysia. Perpustakaan
Опубликовано: (1989)

nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial
по: Gridelli C, и др.
Опубликовано: (2018-05-01)

Androgen Receptor Expression in Primary Nonsquamous Cell Rare-Variant Carcinomas of the Head and Neck
по: Siavash Rahimi MD, FRCPath, и др.
Опубликовано: (2017-06-01)

Multicenter study of carbon‐ion radiation therapy for nonsquamous cell carcinomas of the oral cavity
по: Hiroaki Ikawa, и др.
Опубликовано: (2019-09-01)

A Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLC
по: Daichi Fujimoto, MD, и др.
Опубликовано: (2022-02-01)

Gemcitabine: Efficacy in the Treatment of Advanced Stage Nonsquamous Non-Small Cell Lung Cancer
по: Hidetoshi Hayashi, и др.
Опубликовано: (2011-01-01)

P540: RESULTS FROM A PHASE 1 CLINICAL STUDY OF THE ALL-ORAL REGIMEN OF CC-486 AND VENETOCLAX FOR RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
по: Maria Amaya, и др.
Опубликовано: (2023-08-01)

KIE 486 - KIMIA MAKANAN JUN 1994.
по: PPSK, Pusat Pengajian Sains Kimia
Опубликовано: (1994)

Brief Report: Impact of Maintenance Pemetrexed Cessation on Clinical Outcomes of Patients With Metastatic Nonsquamous NSCLC
по: Shreya Bhatia, BS, и др.
Опубликовано: (2024-11-01)

Biomarker Testing for Patients With Advanced/Metastatic Nonsquamous NSCLC in the United States of America, 2015 to 2021
по: Lisa M. Hess, PhD, и др.
Опубликовано: (2022-06-01)

Bevacizumab in the treatment of nonsquamous non-small cell lung cancer: clinical trial evidence and experience
по: Laurent Greillier, и др.
Опубликовано: (2016-10-01)

An Epidemiologic study of Oral and Pharyngeal Nonsquamous Cell Malignant Tumors inKerman province, Iran
по: MR. Zarei, и др.
Опубликовано: (2007-03-01)

Glenn's Suzuki one-cylinder repair and tune-up guide : models 50 cc, 55 cc, 80 cc, 90 cc, 120 cc, 125 cc, 185 cc, 250 cc, 400 cc/
по: 402466 Crawford, Charles W., и др.
Опубликовано: (1972)